| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yoshiki Takai, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Frontiers in neurology. vol 14. 2023-08-07. PMID:37545724. |
pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. |
2023-08-07 |
2023-08-14 |
human |
| Jessica A Kraker, John J Che. An update on optic neuritis. Journal of neurology. 2023-08-05. PMID:37542657. |
although most cases of optic neuritis (on) are classified as typical, meaning idiopathic or associated with multiple sclerosis, there is a growing understanding of atypical forms of optic neuritis such as antibody mediated aquaporin-4 (aqp4)-igg neuromyelitis optica spectrum disorder (nmosd) and the recently described entity, myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). |
2023-08-05 |
2023-08-14 |
Not clear |
| David Berhanu, Miguel Leal Rato, Silvia Messina, Maria Isabel Leite, Ruth Geraldes, Jacqueline Palac. The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-08-02. PMID:37528605. |
the effect of smoking on the resolution of magnetic resonance imaging (mri) lesions in patients with neuromyelitis optica spectrum disorders with aquaporin-4 positive antibody (nmosd-aqp4) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) has not been studied before. |
2023-08-02 |
2023-08-14 |
Not clear |
| Grace Gombolay, Jamika Hallman-Coope. COVID-19 and the Pandemic-Related Aspects in Pediatric Demyelinating Disorders. Seminars in pediatric neurology. vol 46. 2023-07-14. PMID:37451752. |
cases of myelin oligodendrocyte glycoprotein antibody disease, neuromyelitis optica spectrum disorder, and multiple sclerosis are also described. |
2023-07-14 |
2023-08-14 |
Not clear |
| Jana Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy, Robert Hoepner, Christopher Linington, Andrew Chan, Jeffrey L Bennett, Volker Enzmann, Anke Salme. Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 5. 2023-07-10. PMID:37429715. |
mechanisms of visual impairment in aquaporin 4 antibody (aqp4-igg) seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody (mog-igg)-associated disorder (mogad) are incompletely understood. |
2023-07-10 |
2023-08-14 |
Not clear |
| Qiao Xu, Xixi Yang, Zhandong Qiu, Dawei Li, Hongxing Wang, Hong Ye, Lidong Jiao, Jing Zhang, Li Di, Peng Lei, Huiqing Dong, Zheng Li. Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS. Multiple sclerosis and related disorders. vol 77. 2023-07-04. PMID:37402345. |
clinical features of mogad with brainstem involvement in the initial attack versus nmosd and ms. to assess the characteristics of myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) with brainstem involvement in the first event (bsife) and make comparisons with aquaporin-4-igg seropositive neuromyelitis optica spectrum disorder (aqp4-igg-nmosd) and multiple sclerosis (ms). |
2023-07-04 |
2023-08-14 |
Not clear |
| Jessica Frau, Giancarlo Coghe, Lorena Lorefice, Giuseppe Fenu, Eleonora Cocc. The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases. Life (Basel, Switzerland). vol 13. issue 6. 2023-06-28. PMID:37374092. |
multiple sclerosis (ms), neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein antibody disease (mogad) are inflammatory diseases of the central nervous system (cns) with a multifactorial aetiology. |
2023-06-28 |
2023-08-14 |
human |
| Edgar Carnero Contentti, Darin T Okuda, Juan I Rojas, Claudia Chien, Friedemman Paul, Ricardo Alons. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2023-06-15. PMID:37322542. |
mri to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. |
2023-06-15 |
2023-08-14 |
Not clear |
| Edgar Carnero Contentti, Darin T Okuda, Juan I Rojas, Claudia Chien, Friedemman Paul, Ricardo Alons. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2023-06-15. PMID:37322542. |
differentiating multiple sclerosis (ms) from other relapsing inflammatory autoimmune diseases of the central nervous system such as neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is crucial in clinical practice. |
2023-06-15 |
2023-08-14 |
Not clear |
| Hans Lassman. Top ten discoveries of the year: Neuroinflammation. Free neuropathology. vol 1. 2023-06-07. PMID:37283667. |
they include topics related to new mechanisms of inflammation and immune mediated neurodegeneration, which are relevant for multiple sclerosis (publications 1 to 4) and discuss the role of specific autoantibodies against myelin oligodendrocyte glycoprotein or aquaporin 4 in neuromyelitis optica spectrum disorders (publications 5 and 6). |
2023-06-07 |
2023-08-14 |
Not clear |
| M Isabel Leite, Zoya Panahloo, Niall Harrison, Jacqueline Palac. A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD). Multiple sclerosis and related disorders. vol 75. 2023-05-24. PMID:37224631. |
a systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) or aquaporin 4 neuromyelitis optica spectrum disorder (aqp4+ nmosd). |
2023-05-24 |
2023-08-14 |
Not clear |
| M Isabel Leite, Zoya Panahloo, Niall Harrison, Jacqueline Palac. A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD). Multiple sclerosis and related disorders. vol 75. 2023-05-24. PMID:37224631. |
aquaporin-4 antibody positive (aqp4+) neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are rare autoimmune diseases with overlapping phenotypes. |
2023-05-24 |
2023-08-14 |
Not clear |
| Vyanka Redenbaugh, Nicholas H Chia, Laura Cacciaguerra, Jennifer A McCombe, Jan-Mendelt Tillema, John J Chen, A Sebastian Lopez Chiriboga, Elia Sechi, Yael Hacohen, Sean J Pittock, Eoin P Flanaga. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-05-23. PMID:37218499. |
magnetic resonance imaging (mri) t2-lesions resolve more often in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) than aquaporin-4 igg-positive neuromyelitis optica spectrum disorder (aqp4 + nmosd) and multiple sclerosis (ms) in adults but few studies analyzed children. |
2023-05-23 |
2023-08-14 |
Not clear |
| Nikita Dhar, Mritunjai Kumar, Ashutosh Tiwari, Ramanuj Samanta, Ajeet Singh Bhadoria, S Vivekanandhan, Sudhir Saxena, Niraj Kuma. Comparison of clinico-radiological profile, optical coherence tomography parameters, and outcome in MOGAD and Neuromyelitis optica spectrum disorder subtypes: A prospective observational study. Journal of neurosciences in rural practice. vol 14. issue 2. 2023-05-15. PMID:37181176. |
the objectives of the study were to compare the clinico-radiological profile, optical coherence tomography (oct) parameters and outcome in myelin oligodendrocyte glycoprotein-igg-associated disorders (mogad) and neuromyelitis optica spectrum disorder subtypes. |
2023-05-15 |
2023-08-14 |
Not clear |
| Chirag Sunil Lalwani, Fida Faisal, Anjali Yadav, Sudheeran Kannoth, Vivek Nambiar, Sibi Gopinath, Anand Kumar, Saraf Udit Umesh, Jino Vincent, Sruthi Anoop, Annamma Mathai, Suprabha Panicke. The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia. Multiple sclerosis and related disorders. vol 75. 2023-05-01. PMID:37126965. |
neuromyelitis optica spectrum disorders (nmosd) is an autoimmune syndrome that is frequently positive for aquaporin 4 (aqp4) igg or myelin oligodendrocyte glycoproteins (mog) igg. |
2023-05-01 |
2023-08-14 |
Not clear |
| Kathryn B Holroyd, Sarah E Conwa. Central Nervous System Neuroimmunologic Complications of COVID-19. Seminars in neurology. 2023-04-20. PMID:37080234. |
autoimmune disorders of the central nervous system following covid-19 infection include multiple sclerosis (ms), neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune encephalitis, acute disseminated encephalomyelitis, and other less common neuroimmunologic disorders. |
2023-04-20 |
2023-08-14 |
Not clear |
| Tetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, Kumi Nakaya, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Fumi Itabashi, Ikumi Kanno, Kimihiko Kaneko, Toshiyuki Takahashi, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima, Atsushi Hozaw. White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease. Scientific reports. vol 13. issue 1. 2023-04-20. PMID:37081126. |
white blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease. |
2023-04-20 |
2023-08-14 |
human |
| Tetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, Kumi Nakaya, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Fumi Itabashi, Ikumi Kanno, Kimihiko Kaneko, Toshiyuki Takahashi, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima, Atsushi Hozaw. White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease. Scientific reports. vol 13. issue 1. 2023-04-20. PMID:37081126. |
white blood cell (wbc) count profiles in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and anti-myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are still unknown. |
2023-04-20 |
2023-08-14 |
human |
| Yuki Matsumoto, Kimihiko Kaneko, Toshiyuki Takahashi, Yoshiki Takai, Chihiro Namatame, Hiroshi Kuroda, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain : a journal of neurology. 2023-04-16. PMID:37061817. |
the spectrum of myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) includes optic neuritis (on), myelitis (my), acute disseminated encephalomyelitis (adem), brainstem encephalitis, cerebral cortical encephalitis (ce), and aquaporin-4-igg (aqp4-igg)-negative neuromyelitis optica spectrum disorder (nmosd). |
2023-04-16 |
2023-08-14 |
Not clear |
| Edith L Graha. Neuroimmunological Disorders: The Gender Effect. Neurologic clinics. vol 41. issue 2. 2023-04-08. PMID:37030960. |
treatments for other neuroimmunologic disorders such as neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, neurosarcoidosis, and central nervous system vasculitis may require rituximab before and prednisone or intravenous immunoglobulin therapy during pregnancy. |
2023-04-08 |
2023-08-14 |
Not clear |